SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-014818
Filing Date
2013-03-13
Accepted
2013-03-13 16:20:53
Documents
10
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v336385_10q.htm 10-Q 362193
2 EXHIBIT 31.1 v336385_ex31-1.htm EX-31.1 12826
3 EXHIBIT 31.2 v336385_ex31-2.htm EX-31.2 12886
4 EXHIBIT 32.1 v336385_ex32-1.htm EX-32.1 5129
  Complete submission text file 0001144204-13-014818.txt   3460407

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT csbr-20130131.xml EX-101.INS 483749
6 XBRL TAXONOMY EXTENSION SCHEMA csbr-20130131.xsd EX-101.SCH 38384
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE csbr-20130131_cal.xml EX-101.CAL 31500
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE csbr-20130131_def.xml EX-101.DEF 160364
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE csbr-20130131_lab.xml EX-101.LAB 294936
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE csbr-20130131_pre.xml EX-101.PRE 209227
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-17263 | Film No.: 13687699
SIC: 2836 Biological Products, (No Diagnostic Substances)